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was (8 ± 5.16 months) and (6.31 ± 1.75 kg), respectively.
The age and weight in group B was (7.6 ± 3.9 months)
and (4.84 ± 1.12) kg, respectively. There were no signifi-
cant differences between the two groups in terms of post
operative course, and major complications.
Conclusion: Failure to thrive was not associated with
increase in ICU morbidity and mortality in children
undergoing VSD closure. Attempt to optimize the body
weight for age in children with CHD may not add any
beneficial advantages in term of surgical risk or postoper-
ative ICU outcome.
http://dx.doi:10.1016/j.jsha.2012.06.192
Impact of obesity on survival and New York Heart
Association functional class in patients with sys-
tolic heart failure
Alaa Tayiem
Background: Several studies have shown that in
patients with heart failure (HF), obesity is not associated
with increased mortality, but rather is associated with
improved survival. This has been referred to as the
‘‘obesity paradox’’.
Objective: To examine the impact of body mass
index (BMI) on survival and New York Heart Association
(NYHA) functional class in a Saudi outpatient population
with chronic systolic HF.
Method: This retrospective, descriptive study, ana-
lyzed data from patients with chronic systolic HF and
ejection fraction less than or equal 40% attending a Car-
diovascular Disease Management program (CVDMP)
over a mean follow-up of 48 months.
Patients were classified according to their baseline
BMI. Continuous variables were presented as mean
and frequencies while categorical variable presented as
percentages.
Risks associated with BMI groups were evaluated
using multinomial logistic regression model.
Results: Mortality in the total population (n = 903)
was 3.3% where 47% were above age of 60 and 77% were
male. Significant co-morbidities included; 67% diabetes
mellitus, 67% hypertension, 12% bronchial asthma, 11%
thyroid problems, 6% renal failure and 36% of patients
had an EF less than 25%.
BMI showed significant increase in the last follow-up
compared to baseline (p < 0.000). Obesity, measured by
BMI, showed no statistical impact on mortality
(p < 0.319), but did significantly impact NYHA functional
class (p < 0.023).
Conclusion: There was a chronological increase in
BMI, and, although this had no significant impact on
mortality, it had a significant negative impact on NYHA
functional class.
http://dx.doi:10.1016/j.jsha.2012.06.193
Improvement of mitral regurgitation after trans-
catheter aortic valve implantation (TAVI)
Husain Alamri, Ali Almasood, Saeed Alahmari,
Saad Alkasab, Mohamed Alotaibi, Abdulrahman
Almoghairi, Moheeb Alabdalah
Objectives: To assess the change in mitral regurgita-
tion (MR) severity after transcatheter aortic valve implan-
tation (TAVI).
Background: Mitral regurgitation (MR) is frequently
present in patients with calcific aortic stenosis (AS). Fol-
lowing surgical aortic valve replacement, improvement
in MR is reported in 27–82% of the patients. The changes
in MR severity following TAVI are unknown.
Methods: From April 2009 to January 2011, 57
patients with severe symptomatic aortic stenosis under-
went TAVI [40 cases Edwards Sapien valve (Edwards
Lifesciences Inc, Irvine CA), and 17 cases the CoreValve
ReValving System]. Transthoracic echocardiography
was performed before and 3 months after successful
TAVI procedure. MR was assessed by expert readers
and by color flow mapping and was graded as none
(grade 0), mild (grade 1), moderate (grade 2), moderately
severe (grade 3) or severe (grade 4).
Results: The mean MR grade was 1.7 ± 1.0 and
0.9 ± 0.7 pre- and post-TAVI respectively (p
value < 0.001). MR pretreatment was grade 0–1, grade 2,
and grade 3–4 in 69%, 19%, and 12% of the patients,
respectively. Six patients out of 7 ( 85%) with grade 3–4
demonstrated improvement (4 patients (57%) improved
to mild, and 2 patients (28%) to moderate MR). Seven
patients out of 11 (63%) with grade 2 demonstrated an
improvement to grade 0–1. There was no association
between the improvement of MR and the type of valve
used.
Conclusions: MR improved significantly after TAVI
for severe AS. Further study with careful echocardio-
graphic evaluation of the mitral valve prior to TAVI
may help to predict which patients should experience
an improvement in their MR.
http://dx.doi:10.1016/j.jsha.2012.06.194
Catheter intervention for branch and crossed pul-
monary arteries
Ali Al Akhfash, Mansour Al Mutairi, Omar
Tamimi, Fahad Al Habshan
Introduction: Over the last decade, stent implanta-
tion has become a widely accepted, effective therapy for
the treatment of pulmonary arterial (PA) stenoses. Stent
implantation has proved to be a safe procedure with min-
imal complications.
Objectives: To review our experience with branch
PA stenting. We reviewed also catheter based interven-
tions for patients with right aortic arch and crossed pul-
monary arteries associated with branch PA stenosis.
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Method: Retrospective data analysis of all patients
who had branch PA stenting at KACC, NGHA, Riyadh
KSA, during the period from January 2006 till October
2009. Patients with pulmonary atresia VSD and MAPCAS
were excluded.
Results: Twenty-one patients were identified to have
PA stenting during the study period. 14 were females
(66.7%). Six patients (29%) were syndromic (Alagile syn-
drome, DiGeorge syndrome, Down syndrome, Golden-
har Syndrome, and Noonan Syndrome). Five patients
(24%) had crossed Pas. Seven patients (33%) had PA,
VSD, PDA, Two had TOF, one had AVSD with TOF,
one DORV, one TGA, one truncus arteriosus with IAA
type B, and one had Bicuspid AV with aortic stenosis as
a primary diagnosis. All of them had branch PA stenting
as a secondary procedure (post surgical intervention). Six
patients (29%) had PA stenting as a primary intervention
with no prior surgical intervention. Six patients (29%)
had Bilateral branch PAs stenting, 11 (52%) had LPA
stenting and 4 (19%) had RPA stenting. The median age
at branch PA stenting was 35 months (range 2 months
to 45 years). The median weight was 10.5 kg (2.8–
100 kg). The median F/U period was 32 months (40 days
to 61 months). Ten patients (48%) required stent dilata-
tion after a median period of 28 months (12–38 months).
One patient had failed LPA stenting (stent embolized
and parked into RPA) who later underwent another
intervention with successful LPA stenting.
Conclusion: Stent implantation has proved to be a
safe procedure with minimal complications.
Even in those with crossed Pas. Restenoses is long
term concerns which are amenable to redilatation with
excellent results.
http://dx.doi:10.1016/j.jsha.2012.06.195
Echocardiographic predictors of coarctation of the
aorta
Ali Al Akhfash, Abdulrahman Almsnid, Maan
Hasson, Badr Alharbi, Abdullah AlGhamdi
Background: Echocardiography is the main diagnos-
tic modality of coarctation of the aorta especially in
infants less than 3 months. Sometimes it is difficult to
diagnose coarctation of the aorta either because of poor
echo window or because of the presence of a large
PDA. Failure or delay in the diagnosis of coarctation will
lead to morbidity as well as mortality.
Objectives: The objectives of our study were to look
for echocardiographic predictors of coarctation of the
aorta.
Methods: During the period from September 2010 to
July 2011 echocardiographic measurements were per-
formed for 67 normal infants referred for echocardiogra-
phy. This was compared with 37 patients with proved
coarctation either by surgery or cath. Echocardiographic
measurements performed in both groups include aortic
annulus, ascending aorta diameter, proximal transverse
arch diameter, distal transverse arch diameter, aortic
isthmus diameter, distance between aortic arch branches.
Aortic valve anatomy , associated findings as well as sur-
gical and cath diagnosis were reviewed. The ratio
between the transverse arch and ascending aorta as well
as between transverse arch and the distance between
aortic arch branches were calculated. We compared both
groups using SPSS statistical software. Measurements
were done online as well as offline.
Results: During the study period 67 normal infants
and 37 infants with coarctation were reviewed. The age
group were from one day to one year and the mean
weight were 4.48 ± 1.67 and 3.8 ± 2.19 kg for the normal
and abnormal groups, respectively. There were no statis-
tical difference between the two groups regarding the age
weight as well as the gender. There were statistical differ-
ence in the echocardiographic measurements between
the two groups regarding the transverse arch diameter
with a smaller diameter in the CoA group (3.89 ± 1.17 vs
5.8 ± 1.05 mm, P value 0.0001). The ratio between the
transverse arch and the ascending aorta was smaller in
patients with CoA (0.55 ± 0.16 vs 0.73 ± 0.16, P value
0.0001). The distance between the left common carotid
and the left subclavian arteries was longer in patients
with CoA compared to those with normal arch
(4.76 ± 2.37 mm vs 2.85 ± 1.59 mm, P value 0.0012). The
ratio between the distance between the left common car-
otid and the left subclavian arteries to that of the trans-
verse aortic arch diameter was higher in patients with
Co (1.3311 ± 0.71 vs 0.54 ± 0.29, P value 0.0001). Bicuspid
aortic valve was found in 57% of patients with CoA com-
pared to only 6.5% of patients without coarctation (P
value 0.0001).
Conclusions: Echocardiographic predictors of coarc-
tation of the aorta include the presence of bicuspid aortic
valve, hypoplasia of the transverse arch, smaller ratio
between the transverse arch and the ascending aorta
and high ratio between the distance between aortic arch
branches and transverse aortic arch.
http://dx.doi:10.1016/j.jsha.2012.06.196
Importance of early management of pulmonary
artery hypertension among Adult with Congenital
Heart Disease (ACHD)
Ali Ahmed, Bashiar Alshahri, Danya Arafa, Joe
Frankie, Ahmad S. Omran
Background: Pulmonary artery hypertension (PAH)
is a significant risk factor in patients with congenital heart
disease. If left untreated, PAH can lead to reduced qual-
ity of life and functional class due to pulmonary vascular
damage and right ventricular failure (RV).The prevalence
of PAH in ACHD is estimated to be between 5% and 10%.
In severe cases of PAH, treatment options are generally
limited to palliative measures or heart–lung transplant.
Early treatment of PAH improves quality of life and
may reduce utilization of acute care facilities.
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